ALKBH5 and neoplasm: analysed only 290 GC tumour samples and 22 normal samples obtained from the TCGA‐Stomach adenocarcinoma database, and the number of patients included in our GC cohort was 49.21 We analysed the ACRG GC cohort (n = 300) and found a shorter OS, RFS and DFS with higher ALKBH5 expression in GC.42